CLDX
Celldex Therapeutics Inc
31.10$
-1.2%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +172.3% | -96.2% | +1,501.3% | +27.7% | -63.2% | -40.9% | +5.0% | -100.0% | – | -80.0% | +46.7% | – | |
| – | +3,866.9% | -97.5% | +2.8% | +5,579.2% | -98.2% | +6,324.2% | +3.0% | +16.1% | – | – | – | – | |
| – | -3,606.0% | – | – | -2,573.4% | – | -14,684.0% | – | – | – | -1,218.7% | – | – | |
| – | -11.9% | +1.5% | +25.9% | +16.4% | +1.9% | +14.1% | +3.0% | +16.1% | +19.7% | -3.1% | -7.5% | – | |
| – | +7.4% | +3.1% | +0.3% | +10.1% | +2.1% | +5.4% | -4.0% | +2.8% | +11.4% | -3.8% | +14.4% | – | |
| – | -49.2% | +87.5% | +20.1% | -79.1% | +460.8% | -80.8% | -4.0% | +2.8% | +716.6% | -4.2% | -3.5% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -94.5% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.